{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:46:05Z","timestamp":1782981965527,"version":"3.54.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acne vulgaris is one of the most common inflammatory skin conditions in adolescents, affecting up to 85% of individuals aged 12\u201324 years. Beyond its physical manifestations, acne can significantly impact self-esteem, quality of life, and psychological well-being.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Acne has a multifactorial pathogenesis involving follicular hyperkeratinization, increased sebum production, Cutibacterium acnes colonization, and inflammation. Hormonal influences, particularly androgen-mediated sebaceous gland activity during adrenarche, play a central role in disease development. In some patients, hormonal factors may be more prominent, with clinical features including acne concentrated on the lower face and jawline and flares associated with the menstrual cycle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Recognition of acne as a chronic inflammatory condition has supported the increasing use of hormonal therapies as an important treatment option in selected adolescent patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000001589","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:00:44Z","timestamp":1781787644000},"page":"396-401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Hormonal acne therapies in pediatrics"],"prefix":"10.1097","volume":"38","author":[{"given":"Carla","family":"Torres-Zegarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia Guelfand","family":"Warnken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S2352-4642(22)00314-5","article-title":"Adolescent acne vulgaris: current and emerging treatments","volume":"7","author":"Layton","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.2021.17633","article-title":"Management of acne vulgaris: a review","volume":"326","author":"Eichenfield","year":"2021","journal-title":"JAMA"},{"key":"R3-20260702","article-title":"Screening and management of the hyperandrogenic adolescent","author":"Jennie","year":"2019","journal-title":"Am Coll Obstet Gynecol"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1097\/AOG.0000000000003475","article-title":"Screening and Management of the Hyperandrogenic Adolescent: ACOG Committee Opinion, Number 789","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"R6-20260702","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","article-title":"Acne vulgaris","volume":"379","author":"Zaenglein","year":"2018","journal-title":"New Engl J Med"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/MOP.0000000000000515","article-title":"Endocrine disorders and hormonal therapy for adolescent acne","volume":"29","author":"Nguyen","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"R8-20260702","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.det.2018.12.002","article-title":"An overview of acne therapy, part 2: hormonal therapy and isotretinoin","volume":"37","author":"Marson","year":"2019","journal-title":"Dermatol Clin"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"e14680","DOI":"10.1111\/dth.14680","article-title":"Spironolactone in adolescent acne vulgaris","volume":"34","author":"Dhurat","year":"2021","journal-title":"Dermatol Ther"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"e0298155","DOI":"10.1371\/journal.pone.0298155","article-title":"The efficacy of topical clascoterone versus systematic spironolactone for treatment of acne vulgaris: a systematic review and network meta-analysis","volume":"19","author":"Basendwh","year":"2024","journal-title":"PLoS One"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"e14609","DOI":"10.1111\/dth.14609","article-title":"Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"34","author":"Alkhodaidi","year":"2021","journal-title":"Dermatol Ther"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"e0250155","DOI":"10.1371\/journal.pone.0250155","article-title":"Quality of life in montenegrin pupils with acne","volume":"16","author":"\u0110urovi\u0107","year":"2021","journal-title":"PloS One"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/jdv.15048","article-title":"Which acne treatment has the best influence on health-related quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes","volume":"32","author":"Chernyshov","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20260702","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/ced.14239","article-title":"Acne treatments: future trajectories","volume":"45","author":"Dessinioti","year":"2020","journal-title":"Clin Exp Dermatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001589","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:00:34Z","timestamp":1782979234000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001589","relation":{},"ISSN":["1531-698X"],"issn-type":[{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}